All official European Union website addresses are in the europa.eu domain.
See all EU institutions and bodies
Giorgio Nicoli, CCA
The Asian tiger mosquito (Aedes albopictus) has been present in Italy since 1990, spreading across the entire country, and triggering multiple outbreaks of Chikungunya (2007, Emilia-Romagna, 330 cases; 2017, Lazio and Calabria; respectively 146 confirmed and 93 probable and 55) and dengue. Conventional chemical and biological control have proved insufficient to reduce populations below epidemic risk or nuisance thresholds, and growing insecticide resistance in Italian Aedes albopictus populations is further limiting available tools.
Climate change is expected to foster a substantial expansion of the area of various mosquito species in Europe, including Aedes albopictus (see ECDC). Although SIT has been developed for the control of the current population of mosquitoes and other insects, without any specific climate adaptation goal, it is a promising strategy to help curb and control such expected expansion.
Since 1999, the Centro Agricoltura Ambiente (CAA) 'Giorgio Nicoli', based in Crevalcore (Bologna), has developed and progressively scaled up a SIT programme targeting Aedes albopictus, working with the International Atomic Energy Agency (IAEA) and a network of European and Italian research partners. The programme progressed from laboratory optimisation through open-field pilot releases: the first European SIT pilot trial was conducted in Desenzano del Garda in 2003; subsequent pilot projects were carried out in Bologna (2021–2025) and on Procida Island (Gulf of Naples). A modular prototype facility currently produces up to one million sterile males per week, with a planned bio-farm designed for ten million males per week in the detailed design phase. SIT has also been applied and validated in other European countries (Germany, Greece, Switzerland) using sterile males produced at the CAA facility, establishing a transnational operational network.
Case Study Description
Challenges
Mosquito-borne diseases are an emerging public health challenge in Europe, driven by the spread of invasive mosquito species capable of sustaining outbreaks of tropical arboviral diseases. Among these, Aedes albopictus (the Asian tiger mosquito) is the most invasive mosquito species established in Europe and the most dangerous invasive vector on the continent (Giunti et al, 2023). First reported in Europe in Albania in 1979, it is now established across multiple EU/EEA countries. Italy is one of the most heavily infested countries in Europe: Aedes albopictus was first recorded in Genova in 1990 and rapidly colonised urban and suburban environments across the entire country, particularly in north-eastern and central-southern coastal areas, including major and minor islands. The species exploits a wide variety of man-made water containers (discarded tyres, flowerpots, blocked gutters, cemetery vases) for laying eggs, linking its spread closely to urbanisation patterns.
From a public health perspective, Aedes albopictus is a vector for more than 22 arboviruses, including Chikungunya virus (CHIKV), dengue virus (DENV), and Zika virus (ZIKV). Italy and France together account for 98.5% of autochthonous arboviral cases in Europe attributed to Aedes albopictus (Cholvi et al., 2026). The 2007 outbreak in Emilia-Romagna (330 cases) was the first autochthonous Chikungunya transmission event in Europe. A second major outbreak in Lazio and Calabria in 2017 resulted in over 500 cases, including cases in metropolitan Rome. In 2025, a large European Chikungunya epidemic resulted in 384 autochthonous cases in Italy alone, representing an escalating trend, on infective diseases run by Italian National Institute of Health (Istituto Superiore di Sanità, ISS). West Nile Virus (WNV), transmitted by native Culex species, is also a growing threat: Italy recorded 773 locally acquired WNV cases in 2025, the highest country total in Europe (Epicentro, ISS, 2025).
Climate change is a key driver exacerbating these risks. According to Copernicus, Europe is the fastest-warming area of the world, after the Arctic. Rising temperatures, shifting precipitation patterns, human-driven habitat changes, and prolonged transmission seasons have increased the risk of arboviral outbreaks. Temperature directly affects mosquito biology: warmer winters extend the active season of Aedes albopictus, warming temperatures accelerate larval development and increase blood-feeding frequency, and the extrinsic incubation period of arboviruses within the mosquito shortens as temperatures rise, increasing transmission probability. High temperature and low relative humidity may reduce mosquito longevity, making things more complicated. Evidence from Greece shows that WNV can now persist in adult mosquito populations over winter, a pattern previously unseen in temperate Europe, suggesting that milder winters are enabling extended or year-round virus activity (Cholvi et al., 2026). Modelling studies for Greece and Italy indicate that projected temperature and precipitation shifts will create increasingly favourable conditions for invasive mosquito species establishment by mid-century, with spatial risk maps showing a clear expansion of climatically suitable areas. Flooding events linked to more intense precipitation increase the number of breeding habitats, boosting mosquito populations. Urbanisation further amplifies these dynamics: populations exceeding 1000 inhabitants/km² have been linked to elevated arboviral disease levels, and expanding urban environments create favourable ecological niches for Aedes (Kolimenakis et al, 2021).
Existing mosquito control strategies face mounting challenges. Conventional adulticides (mainly pyrethroids) and larvicides (Bti, Lysinibacillus sphaericus) are the cornerstone of Italian vector control, but insecticide resistance is a growing and serious problem. The ongoing restriction of biocides under the EU Biocidal Products Regulation (EU) 528/2012 has further reduced product availability. These converging pressures — expanding vector range under climate change, increasing insecticide resistance, regulatory constraints on chemical control, and rising arboviral transmission — make the development of innovative, sustainable vector control tools both urgent and necessary.
The economic costs of Aedes albopictus and its associated diseases are also substantial. The cumulative global economic cost of Aedes albopictus and Aedes aegypti exceeded US$94.7 billion (about 83 billion Euro using 2020 the exchange rate) over 45 years (1975–2020), rising to US$318 billion about 279 billion Euro using 2020 the exchange rate) when long-term consequences (chronic osteoarthritis after chikungunya, neurological impacts of Zika) are included (Roiz et al, 2024). European data are underreported, but arboviral outbreaks generate direct healthcare costs, productivity losses, and costs to the tourism sector, which are particularly relevant in coastal Italian regions and Mediterranean islands.
Policy context of the adaptation measure
Case partially developed, implemented and funded as a climate change adaptation measure.
Objectives of the adaptation measure
The primary objectives of the SIT programme are:
(i) Public health: to reduce Aedes albopictus population densities in urban and suburban areas below thresholds for epidemic transmission of arboviruses (chikungunya, dengue, Zika) and below nuisance thresholds for residents and tourists, in a context where conventional insecticide-based control is increasingly insufficient.
(ii) Environmental sustainability: to develop and validate a species-specific, insecticide-free vector control method that avoids the non-target effects of conventional chemical control on beneficial arthropods (including pollinators), reduces the risk of insecticide resistance development, and does not leave chemical residues in the environment.
(iii) Technological and operational readiness: to advance the mass-rearing, sexing (Mechanical separation of males and females), sterilisation, quality control, packaging, and release technologies for Aedes albopictus sterile males to the level required for operational deployment at scale, and to transfer this knowledge to other institutions internationally.
(iv) Climate change adaptation: to provide a robust, insecticide-independent complementary tool within area-wide integrated pest management (AW-IPM) programmes that remains effective under a range of climate scenarios associated with expanding vector range, longer transmission seasons, and increasing arboviral outbreak frequency.
Solutions
SIT is a biological pest control approach in which large numbers of sterilised male insects are mass-reared and released into wild populations. Sterile males compete with wild males to mate with wild females; matings with sterile males produce no viable offspring, progressively suppressing the local population. SIT has been employed globally for over 60 years in area-wide integrated pest management (AW-IPM) programmes against agricultural, veterinary, and medically important insect pests (see for instance, IAEA’s Insect pest Control Section). Common to all genetic control strategies, including SIT, is the absence of any effect on non-target species and the environment, because released sterile males exercise their suppressive action only against conspecific individuals.
Aedes albopictus is particularly suitable for SIT application due to three key biological properties: (a) its spread is concentrated in urban and suburban areas rather than in natural or agricultural habitats, reducing the target area to be treated; (b) its active dispersal is limited to a few hundred metres from breeding sites, improving the achievable ratio of sterile to wild males in a release area; and (c) it is relatively amenable to mass rearing under artificial conditions.
The process currently applied at CAA 'Giorgio Nicoli' centre envisages the following stages:
· A bloodmeal is provided to female mosquitoes using blood sourced from nearby slaughter facilities, eliminating the need for host animals. Larval rearing is fully standardised to ensure homogeneous and reliable male production at scale.
· Sexing is performed at the pupal stage, exploiting the size difference between male and female pupae. Only males are retained for release, as female mosquitoes bite and could potentially transmit pathogens. AI-based technologies to achieve highly accurate automated sexing have recently become available and are expected to further increase male yield. The percentage of wrong sex attributions is currently less than1 %.
· Male pupae are sterilised by X-ray irradiation while submerged in water, a method that maintains high sterility levels while preserving male competitiveness.
· Sterile male quality is routinely monitored for longevity, flight capacity, and degree of sterility before any field release. Quality of transported sterile males can also be assessed via residual longevity of field-recaptured individuals.
· A packaging system suitable for air shipment by express courier has been developed, enabling the supply of sterile males to distant release sites across Italy and Europe.
Field releases and results
The first European SIT pilot trial was conducted in Desenzano del Garda (Italy) in 2003, using mass-reared, gamma-irradiated Aedes albopictus males and resulted in a reduction in both egg density and fertility. Subsequent trials demonstrated that sterile males released at rates of 896-1,590 males/ha/week induced significant sterility in the local population, with a 70-80% reduction in egg fertility corresponding to a significant decrease in egg density in the study area (Bellini et al, 2013).
The Bologna municipal pilot (2021-2025) is the most sustained operational deployment to date. Releases were also carried out on Procida Island (Gulf of Naples), chosen for its semi-isolated geography and for an earlier four-year citizen-science study that had established baseline population dynamics and community acceptance. Beyond Italy, sterile males produced at CAA have supported successful field trials in Germany (Southwest Germany, integrated with routine IVM), Greece (Vravrona, Attica Region: 2018-2019 trials achieved elevated egg sterility in 5-10 ha sites; large-scale boosted-SIT also tested in 2025), and Switzerland (Morcote: large-scale trial over 45 ha showing significant reductions in egg counts, egg hatching, and female density) (Parrondo Monton et al, 2025). In Bologna, the releases of sterile male tiger mosquitoes are carried out twice a week (roughly Monday and Thursday), from May until the end of September, using a vehicle made identifiable with a flashing light and identifying plates. In terms of volume, between 50,000 and 120,000 sterile males are released per operation. SIT is integrated with door-to-door larvicide applications in cooperation with residents, who are given free flagons of the larvicide to be applied directly by residents during the mosquito season. This door-to-door larvicide activity serves the purpose of reducing the area's mosquito productivity so as to limit the number of sterile males that need to be released.
Development of aerial distribution systems using drones is underway and field tests were conducted in 2024. This technology provides a scalable and precise release mechanism for urban environments and is expected to reduce operational costs per unit area.
A modular prototype breeding plant is currently operational with a capacity of one million sterile males of Aedes albopictus per week. A bio-farm designed to produce ten million sterile males per week is in the detailed design phase, representing a transition from pilot/demonstration phase to routine operational deployment.
Sterile male quality is monitored through standardised bioassays (longevity, flight capacity, sterility levels) at the production stage. Field effectiveness is assessed through ovitrap-based population monitoring (egg density and fertility) and adult capture during pilot releases. Quality control parameters for Aedes albopictus SIT programmes have been formally documented and published by the European research network. The four general goals of SIT field evaluation — early detection, population monitoring, risk assessment, and efficacy evaluation — align with those described in the ECDC guidelines for mosquito surveillance (ECDC; 2012).
Additional Details
Stakeholder participation
The SIT programme has involved a broad, evolving, multi-stakeholder network across more than 25 years. Key categories of actors include:
CAA 'Giorgio Nicoli' has been collaborating on SIT with several research institutions and universities such as: the University of Bologna (Department of Agricultural Sciences); University La Sapienza Rome (Department of Genetic and Molecular Biology); University Federico II Naples (Department of Biology); ENEA CR Casaccia (Biotec-Agro Section, Rome); University of Applied Sciences and Arts of Southern Switzerland (SUPSI); and the Benaki Phytopathological Institute (Athens, Greece).
IAEA has been a central partner since 2007, providing technical guidelines, co-funding, and the framework for CAA's designation as an IAEA Collaboration Centre in 2011. IAEA’s central role stems directly from its mission of fostering and monitoring the peaceful uses of radioactive materials, of which mosquito males’ sterilisation is a direct application. Ongoing involvement of IAEA and multiple EU research programmes ensures continuous technological upgrading.
Funding and operational support has been provided by local and regional governments and public health bodies, such as the Municipality of Bologna (2021-2025), the Municipality of Desenzano del Garda (1999-2003), the Municipality of Rimini (2004), ENIA Reggio Emilia (2008–2009), the Emilia-Romagna Region (2005-2015), and ASL Brescia (1999-2000). The German Mosquito Control Association (GFS) and the Sanitary Physic Service of S. Anna Hospital Ferrara have also been involved. In Procida, SIT application and the subsequent scientific analyse were financed by Università degli Studi di Napoli Federico II” to MS in 2016 and 2017, by a grant from Comitato di Gestione della Riserva Naturale Statale Isola di Vivara to MS in 2018 and by EU funded projects H2020-MSCA-NIGHT-2018 and H2020-MSCA-NIGHT-2020.
Citizens and community: On Procida Island, the SIT procedure was preceded by a 4-year (2015-2019) citizen science study program (STOPTIGRE), conducted in strict collaboration with local administrators and citizens to estimate temporal dynamics, spatial distribution, and population size of Aedes albopictus. This study documented positive community attitudes towards participating in innovative mosquito control projects, providing the evidence base for planning of field interventions. The program has been renewed and extended until 2024, when the first SIT application on the island took place. Community engagement is recognised in the scientific literature as essential for SIT success: successful SIT programmes depend not only on technical performance but on strong community engagement, transparent communication, careful site selection, and integration into broader vector management frameworks. Knowledge, Attitude and Practice (KAP) surveys conducted before SIT releases in Greece demonstrated the value of pre-release community preparation, including door-to-door campaigns that helped raise public awareness, reduced breeding sites, and strengthened community involvement. Similar approaches are relevant for the Italian pilots.
Citizen science has also been deployed more broadly in Italian and European mosquito surveillance: Mosquito Alert, a pioneering citizen science platform launched in 2014, has demonstrated that citizen participation can reduce surveillance costs by up to eightfold compared with traditional methods.
Success and limiting factors
Success factors:
Political and governance: Long-term and multi-level institutional support from the Italian Ministry of University and Research, multiple municipalities, the Emilia-Romagna Region, and successive EU Framework Programmes spanning over two decades has provided the stable funding environment necessary for a sustained research-to-application pipeline. The IAEA partnership and Collaboration Centre status have provided international legitimacy and access to global SIT expertise.
Regulatory: The Commission Implementing Decision (EU) 2018/1623 clarified that irradiation-sterilised mosquitoes released for vector control (SIT) are not considered biocidal products under the BPR, providing a comparatively straightforward regulatory pathway that has not been available to other genetic control strategies. This is a significant advantage: Cholvi et al. (2026) notes that while SIT for insect control is already regulated in Europe, the experimentation of other genetic control strategies still requires specific regulatory frameworks.
Technical: The biological characteristics of Aedes albopictus make it particularly well suited to SIT: its urban spread pattern limits the target area; its limited dispersal improves achievable sterile/wild male ratios; and it is amenable to mass rearing. Cumulative technical advances (mechanical pupal sexing, X-ray sterilisation in water, standardised quality control, courier-compatible packaging, and drone-based release systems) have progressively de-risked operational deployment. AI-based sexing technologies offer further improvements in male yield and female exclusion. Moreover, the literature highlights that the integration of SIT with other vector control measures, particularly larvicides such as Bti-based products, and the exploitation of released males to self-disseminate insect growth regulators (IGRs, e.g., pyriproxyfen) to breeding sites, can increase the effectiveness and sustainability of the approach. Boosted-SIT trials combining sterilised males with pyriproxyfen coating have been tested in Spain and Greece, demonstrating the potential of SIT integration within broader IVM frameworks
Social: Citizen science studies on Procida Island established community acceptance and baseline data simultaneously, demonstrating an efficient model for pre-release preparation. The available literature shows that European communities exposed to high Aedes albopictus densities generally have a positive attitude towards innovative control methods when properly informed.
Limiting factors:
Technical: Achieving consistently competitive sterile males is a persistent challenge; male mating competitiveness can be reduced by the irradiation process. Quality control monitoring is therefore central to the programme. Aedes albopictus females may mate only once, meaning that mating with a sterile male has a permanent effect on fertility — but achieving sufficient sterile/wild male ratios in the field requires continuous, high-volume releases.
Physical and biological: Aedes albopictus populations are not naturally isolated in most Italian urban environments (including Bologna), and immigration of wild individuals from surrounding areas can continuously replenish the local population, reducing the achievable suppression level. Procida Island was selected partly for its semi-isolated geography, but immigration remains a challenge. Suppression-based strategies such as SIT are self-limiting: effects drop rapidly after releases cease. Currently the eradication of the species is not considered as a feasible target.
Economic: Cholvi et al. (2026) notes that the main limitation of suppression-based genetic control strategies is cost-effectiveness: translating experimental trials into operational programmes requires large investments and long-term programming, including construction and operation of a dedicated bio-farm. The underreporting of the economic burden of Aedes albopictus in Europe currently limits the evidence base for a cost/benefit assessment.
Replication and scaling potential: The programme is explicitly designed for scaling. The planned bio-farm would increase production tenfold to 10 million males/week. Pilot results from Italy have already been used to inform and supply SIT programmes in Germany, Greece, and Switzerland, demonstrating active transnational replication. CAA's role as IAEA Collaboration Centre enables global knowledge transfer.
Costs and benefits
Although quantitative evidence about environmental and socio-economic benefits of SIT is lacking in the case study area, the routine integration of this technique into standard regional and local arbovirus control measures is expected to deliver multiple benefits. More specifically the following benefit categories can be identified:
Environmental co-benefits: SIT is inherently species-specific: only sterile male Aedes albopictus are released, and they have no capacity to bite or transmit disease. Unlike broad-spectrum insecticides, SIT does not affect non-target arthropods, including pollinators. Reduced reliance on adulticide spraying avoids associated impacts on biodiversity and air quality. Cholvi et al. (2026) highlight that large-scale applications of Bti larvicides in seasonal wetlands can significantly reduce chironomid emergence, a non-target effect not associated with SIT. There are no known biodiversity trade-offs from the SIT approach itself. SIT can contribute to a reduction in the overall use of chemical insecticides in target areas, with positive implications for soil and water quality. In terms of robustness and flexibility, the SIT approach is inherently species-specific and does not rely on chemical pesticides, making it robust against insecticide resistance and changes in regulatory availability of biocides. The modular rearing system and drone-based release technology are designed to be scalable and adaptable to different urban settings, population densities, and climate scenarios. Unlike broad-spectrum insecticides, the effectiveness of SIT is not diminished by the warming temperatures associated with climate change.
Public health benefits: Reduction of Aedes albopictus densities below epidemic thresholds would prevent future Chikungunya and Dengue outbreaks. Between 2007 and 2025, Aedes albopictus has caused 2,033 cases of chikungunya and 605 cases of dengue in Europe, with Italy accounting for a large share. The 2025 Italian Chikungunya epidemic (384 autochthonous cases) illustrates the continuing and escalating burden (Cholvi et al., 2026). Prevention of outbreaks translates into avoided hospitalisation costs, reduced work absenteeism, lower burden on the health system, and reduced costs to the blood/organ transfusion system.
Economic benefits for tourism and the regional economy: Reduced mosquito nuisance has direct economic value for coastal and island tourism, which is a major component of the Italian economy. The economic impacts of arboviral outbreaks on tourism revenues in Mediterranean areas remain largely unquantified but they are likely to be substantial (Cholvi et al., 2026). A lower bound for the benefits comes from private spending estimated for Emilia-Romagna region families related to mosquito prevention and control (Canali et al., 2024). That study found that households in Emilia-Romagna spent between EUR 44 and EUR138 per year on mosquito self-protection, with the amount varying according to dwelling characteristics, the presence of children under six years of age, and the degree of concern over the mosquitoes' capacity to transmit disease. Given the 2,029,000 households recorded in the region in 2014, aggregate household spending was estimated at about EUR171,673,690, roughly 0.1% of regional GDP. By comparison, an earlier study put the outlay borne by public bodies (the regional administration, municipalities, and the local health authorities) for delivering the Regional Control Plan at around EUR 5.3 million, or EUR 1.3 per inhabitant, some 32 times lower than household expenditure per inhabitant (Venturelli et al., 2008).
The SIT programme at CAA has been supported across its history by a multi-level funding architecture spanning the Italian Ministry of University and Research, multiple municipalities (Bologna, Desenzano del Garda, Rimini), the Emilia-Romagna Region, and successive EU-funded research infrastructure programmes: EU FP7 INFRAVEC (2009-2014), EU LIFE CONOPS (2013–2018), EU HORIZON2020 INFRAVEC2 (2017-2020), and EU HORIZON-INFRA-2021-EMERGENCY ISIDORe (2022-2025).
Implementation time
The research and development phase started in 1999 and it is still ongoing. The first open-field pilot trial was conducted in Desenzano del Garda in 2003 (Lombardy region), approximately 4 years after laboratory work began. Subsequent pilot releases were conducted in Emilia-Romagna region (Rimini in 2004, Boschi di Baricella in 2008-2009; Caselline di Albinea in 2009; Gherghenzano di San Giorgio in 2012, Bologna in 2021-2025) and in Campania region (Procida Island in 2024). The 4-year citizen science baseline study on Procida Island preceded the field release phase. Planning and construction of the planned 10 million males/week bio farm represents the next major implementation step, timeline not specified in the available sources.
The treatment is applied twice a week throughout the mosquito active season (from May to September, for 20-22 weeks in northern Italy). Climate change may result in longer treatment periods.
Lifetime
The SIT programme is conceived as a continuous operational task rather than a time-limited infrastructure project. Sterile males must be produced and released on a recurrent annual basis to maintain population suppression. Cholvi et al. (2026) emphasise that suppression-based strategies such as SIT are self-limiting; effects drop rapidly after releases cease. Long-term operational sustainability therefore requires continuous funding and production capacity. The modular prototype facility and the planned bio farm are intended as long-term assets. Given the projected expansion of Aedes albopictus range under climate change scenarios, the need for operational vector control tools is expected to grow, not diminish, over the coming decades.
Reference Information
Contact
C.A.A. 'Giorgio Nicoli' S.r.l., Via Sant'Agata n.835, 40014 Crevalcore (BO), Italy
Telephone: +39 051 6802211
Websites
References
Bellini R., Medici A., Puggioli A., Balestrino F., Carrieri M. Pilot field trials with Aedes albopictus irradi ated sterile males in Italian urban areas. J. Med. Entomol. 2013. 50(2): 317–325. https://doi.org/10. 1603/me12048PMID:23540120
Canali M, Vici L, Rivas Morales S, Donati L, Matrangolo C, Venturelli C, et al. (2024) Household expenditure on control of urban mosquitoes Aedes albopictus and Culex pipiens in Emilia-Romagna, Northern Italy. PLoS Negl Trop Dis 18(10): e0012552. https://doi.org/10.1371/journal.pntd.0012552
Cholvi M., Moretti R., Costa Osório H., L'Ambert G., Seixas G., Kavran M., Michaelakis A., Stephanou A.S., Antoniou C.P., Martinou A.F., Roiz D., Calvitti M. and Bueno-Marí R. (2026). Present and Future of Mosquito-Borne Disease Control in Europe with a Specific Focus on the Mediterranean. Insects, 17(3), 254. https://doi.org/10.3390/insects17030254
Epicentro, Istituto Superiore di Sanità (ISS), 2025 Sorveglianza integrata del West Nile e Usutu virus, Bollettino N. 16 del 30 ottobre 2025, https://www.epicentro.iss.it/westnile/bollettino/Bollettino_WND_2025_16.pdf
European Centre for Disease Prevention and Control. Guidelines for the surveillance of invasive mosquitoes in Europe. Stockholm: ECDC; 2012.
Giunti, G., Becker, N., & Benelli, G. (2023). Invasive mosquito vectors in Europe: From bioecology to surveillance and management. Acta Tropica, 239, 106832. https://doi.org/10.1016/j.actatropica.2023.106832
Kolimenakis, A., Heinz, S., Wilson, M. L., Winkler, V., Yakob, L., Michaelakis, A., Papachristos, D., Richardson, C., & Horstick, O. (2021). The role of urbanisation in the spread of Aedes mosquitoes and the diseases they transmit—A systematic review. PLoS Neglected Tropical Diseases, 15(9), e0009631. https://doi.org/10.1371/journal.pntd.0009631
Parrondo Monton D, Ravasi D, Campana V, Pace F, Puggioli A, Tanadini M, Flacio E. Effectiveness of the sterile insect technique in controlling Aedes albopictus as part of an integrated control measure: evidence from a first small-scale field trial in Switzerland.
Infect Dis Poverty. 2025 Aug 22;14(1):90. doi: 10.1186/s40249-025-01360-2. PMID: 40847428; PMCID: PMC12372186. https://pubmed.ncbi.nlm.nih.gov/40847428/
Roiz D, Pontifes PA, Jourdain F, Diagne C, Leroy B, Vaissière AC, Tolsá-García MJ, Salles JM, Simard F, Courchamp F. The rising global economic costs of invasive Aedes mosquitoes and Aedes-borne diseases. Sci Total Environ. 2024 Jul 10;933:173054. doi: 10.1016/j.scitotenv.2024.173054. Epub 2024 May 8. PMID: 38729373. https://pubmed.ncbi.nlm.nih.gov/38729373/
Venturelli C, Zeo SM, Macini P, et al. A regional plan of the Emilia-Romagna regional bureau for Aedes albopictus control--year 2008. Parassitologia. 2008 Jun;50(1-2):129. PMID: 18693578. https://pubmed.ncbi.nlm.nih.gov/18693578/
Published in Climate-ADAPT: Nov 19, 2026
Please contact us for any other enquiry on this Case Study or to share a new Case Study (email climate.adapt@eea.europa.eu)

Language preference detected
Do you want to see the page translated into ?